GSK plc (GSK.L) Stock Analysis

Free AI-powered analysis and research for GSK plc stock

Sector: Healthcare

Analyze GSK plc (GSK.L) Stock

GSK plc (GSK.L) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into GSK.L stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for GSK plc stock.

Analyze GSK.L Now →

📰 Latest Update

GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

Fri, March 13, 2026 at 3:44 PM UTC 3 min read

GSK's RSV vaccine, AREXVY, has received approval in the U.S. for use in adults aged 18-49 years who are at increased risk for respiratory syncytial virus. This expanded indication could significantly boost sales and market share for GSK, as it opens up a new demographic for vaccination. Investors may view this approval as a positive development, potentially enhancing the company's growth prospects in the competitive vaccine market.

Read full article →